Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients

NCT01401010 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Febrile Neutropenia

Interventions

DRUG: Doripenem
DRUG: doripenem

Sponsor

Gary E. Stein, Pharm.D.